0000000001228864

AUTHOR

Christine Zanke

showing 1 related works from this author

Safety and efficacy of outpatient treatment with CPT-11 plus bolus folinic acid/5-fluorouracil as first-line chemotherapy for metastatic colorectal c…

2003

The combination of irinotecan (CPT-11), bolus 5-fluorouracil (5-FU) and folinic acid (FA) (Saltz regimen) has recently been questioned as first-line chemotherapy for metastatic colorectal cancer after high early death rates due to gastrointestinal and thromboembolic events were reported in two US trials. Therefore, we carefully evaluated the safety and efficacy of this regimen, with high value placed on the management of delayed diarrhea. Forty-six patients with metastatic colorectal cancer received this first-line treatment in nine German outpatient clinics. Dose reductions were mandatory from the first cycle in case of toxicity grade2. Chemotherapy was administered only to diarrhea-free p…

AdultMaleOncologyCancer Researchmedicine.medical_specialtyColorectal cancermedicine.medical_treatmentLeucovorinEarly deathIrinotecanFolinic acidBolus (medicine)Internal medicineAntineoplastic Combined Chemotherapy ProtocolsAmbulatory CaremedicineHumansPharmacology (medical)Prospective StudiesAgedPharmacologyChemotherapybusiness.industryLiver NeoplasmsMiddle Agedmedicine.diseasedigestive system diseasesSurgerySurvival RateIrinotecanOncologyFluorouracilCamptothecinFemaleFluorouracilFirst line chemotherapyColorectal Neoplasmsbusinessmedicine.drugAnti-Cancer Drugs
researchProduct